Vaccination policies for healthcare personnel in Europe, 2026
European countries have more comprehensive vaccination policies for HCP compared with 2018, however there are still significant differences between countries.
Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season - COVID-19, RSV, Influenza
JAMA Special Communications - Three systematic reviews identify & summarise recent reporting on the effectiveness and safety of vaccines and influenza/RSV/Covid-19 epidemiology in the US.
(Recording available) IDC Partner Session at WOHC2026 - Exploring bidirectional links between respiratory viruses & non-communicable diseases
Now available to watch On Demand - IDC session at 9th World One Health Congress in Lisbon, 6 September 2026.
Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study
Long COVID is associated with worse cardiovascular fitness. Additional studies are needed to determine if Long COVID is a novel risk factor for incident CVD.
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
Comparing the Australian and New Zealand experiences in the evolving COVID-19 landscape highlights differences in policy and prescribing practice.
Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy
Using symptom and quality of life data, clinical examinations and biofluid proteomics, authors document ocular symptoms persisting from 3 months up to 3 years post-infection.
WHO: New global youth competition on influenza and COVID-19 prevention and control
Submissions will open on Monday 3 August 2026, until Sunday 13 September 2026.
News
Scientific Papers
Reports
How benchmarking of bioinformatics tools is essential for informed workflow selection: a case study on SARS-CoV-2 sgRNA detection
New report from the Joint Research Centre (JRC)